drug
peramivir
Marketedupdated 3mo agoby $BCRX BIOCRYST PHARMACEUTICALS INC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 12, 2027
178 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- May 7, 2027method-of-use (U-3069)US 8778997262d
- Feb 12, 2027method-of-use (U-3069)US 10391075178d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that